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Abstract 
Background: Measurement of systolic and diastolic function in animal models is challenging by conventional non-
invasive methods. Therefore, we aimed at comparing speckle-tracking echocardiography (STE)-derived parameters to 
the indices of left ventricular (LV) pressure–volume (PV) analysis to detect cardiac dysfunction in rat models of type-1 
(T1DM) and type-2 (T2DM) diabetes mellitus.
Methods: Rat models of T1DM (induced by 60 mg/kg streptozotocin, n = 8) and T2DM (32-week-old Zucker Diabetic 
Fatty rats, n = 7) and corresponding control animals (n = 5 and n = 8, respectively) were compared. Echocardiog-
raphy and LV PV analysis were performed. LV short-axis recordings were used for STE analysis. Global circumferential 
strain, peak strain rate values in systole (SrS), isovolumic relaxation (SrIVR) and early diastole (SrE) were measured. LV 
contractility, active relaxation and stiffness were measured by PV analysis.
Results: In T1DM, contractility and active relaxation were deteriorated to a greater extent compared to T2DM. In 
contrast, diastolic stiffness was impaired in T2DM. Correspondingly, STE described more severe systolic dysfunction in 
T1DM. Among diastolic STE parameters, SrIVR was more decreased in T1DM, however, SrE was more reduced in T2DM. 
In T1DM, SrS correlated with contractility, SrIVR with active relaxation, while in T2DM SrE was related to cardiac stiff-
ness, cardiomyocyte diameter and fibrosis.
Conclusions: Strain and strain rate parameters can be valuable and feasible measures to describe the dynamic 
changes in contractility, active relaxation and LV stiffness in animal models of T1DM and T2DM. STE corresponds to PV 
analysis and also correlates with markers of histological myocardial remodeling.
Keywords: Speckle-tracking echocardiography, Invasive hemodynamics, Diabetic cardiomyopathy, Cardiac 
dysfunction, Heart failure, Murine models, HFpEF, HFrEF
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Introduction
Diabetes mellitus (DM) can be divided into four major 
types including type-1 (T1DM) and type-2 DM (T2DM). 
T1DM accounts for 5% of all diabetes cases, while T2DM 
is more common [1]. The number of diabetic adults is 
likely to increase by 69% in developing countries and 20% 
in the developed countries by the year of 2030 [2]. DM 
acts as an independent risk factor for different cardiovas-
cular disorders. The altered metabolism in DM leads to 
the development of diabetic cardiomyopathy [3, 4]. Many 
animal models have been developed throughout the 
recent decades for T1DM and for T2DM to investigate 
the pathophysiology and pharmacology of diabetic cardi-
omyopathy [5]. Our research group published a detailed 
report on characteristic deterioration of cardiac func-
tion in T1DM and T2DM animal models [6]. According 
to our and others’ findings, T1DM is associated with the 
impairment of contractility and active relaxation while in 
T2DM increased cardiac stiffness and diastolic dysfunc-
tion develops [6–8].
Pressure–volume (PV) analysis is the gold standard 
method for the detailed hemodynamic characterization 
of the heart [9]. PV analysis provides the possibility to 
measure intrinsic cardiac function including contractility, 
diastolic function, active relaxation and cardiac stiffness 
independently of loading conditions [10]. In spite of its 
clear advantages, the greatest disadvantage of PV analysis 
is its invasiveness (direct catheterization of the heart) and 
that this method requires the euthanization of the animal.
Transthoracic echocardiography may be an alterna-
tive approach and due to its non-invasive nature it may 
be used in follow-up studies as well. However, conven-
tional parameters derived from two-dimensional and 
M-mode echocardiographic images suffer from several 
shortcomings, including modest sensitivity and techni-
cal limitations [9, 11]. Thus, assessment of contractility 
and diastolic function in diabetic cardiomyopathy is an 
issue for experimental studies. Parameters that are sensi-
tive, reliable and reflect better the systolic and diastolic 
function of the heart are needed. Speckle-tracking echo-
cardiography (STE) is an emerging echocardiographic 
technique that allows to characterize the deformation of 
the myocardium yielding advanced measures of systolic 
and also diastolic function [9, 12].
Based upon that, in the current study we aimed at 
comparing STE with PV analysis for the detection of 
characteristic differences between T1DM- and T2DM-
associated cardiac dysfunction in relevant rodent models.
Methods
Animals
Animals were housed individually in a room with con-
stant temperature and 12/12 h light/dark cycles.
Model of T1DM
For T1DM 8-week-old male Sprague–Dawley rats 
(Charles River, Sulzfeld, Germany) were used. Animals 
received standard laboratory rat diet and water ad  libi-
tum. T1DM was induced with a single i.p. injection of 
streptozotocin (60  mg/kg) (Sigma Aldrich, Budapest, 
Hungary). Streptozotocin was dissolved in citrate buffer 
(pH  =  4.5; 0.1  mol/l). Control animals received only 
the buffer. 72  h after the injection blood glucose con-
centration was determined by using a digital blood glu-
cose meter (Accu-Chek® Sensor, Roche, Mannheim, 
Germany). Animals with a random blood glucose level 
> 15 mmol/l were considered diabetic and included in the 
study. The following study groups were established: non-
diabetic control animals (T1DM Co; n = 5) and animals 
with type-1 DM (T1DM; n = 8). Experiments were per-
formed after 8 weeks of diabetes duration.
Model of T2DM
For T2DM 7-week-old Zucker Diabetic Fatty (ZDF) 
rats (Charles River) were used [6]. Animals develop 
T2DM due to a genetic mutation of the leptin receptor. 
Homozygous recessive males (fa/fa) develop obesity, fast-
ing hyperglycemia and T2DM. Homozygous dominant 
(+/+) and heterozygous (fa/+) lean genotypes remain 
normoglycemic. Animals were fed a special diet (Purina 
#5008) and water ad  libitum. Animals were assigned to 
the following groups: non-diabetic control lean animals 
(T2DM Co; n = 8) and animals with type-2 DM (T2DM; 
n = 7). Experimental procedures were performed at the 
age of 32 weeks (after 25 weeks of diabetes duration).
Measurement of blood glucose
Non-fasting blood glucose was measured by a digital 
blood glucose meter (Accu-Chek® Sensor, Roche, Man-
nheim, Germany) from a drop of blood collected from 
the saphenous vein at the end of the study period.
Echocardiography
Echocardiography was performed at the end of the 
experimental period as described elsewhere [13]. In brief, 
animals were anesthetized with 1–2% isoflurane in 100% 
oxygen, placed on a heating pad (body temperature was 
maintained at 37  °C). Echocardiography was conducted 
by using a 13-MHz linear transducer (GE 12L-RS, GE 
Healthcare, Horten, Norway) coupled with an echocardi-
ography machine (Vivid i, GE Healthcare). Images were 
analyzed with an image analysis software (EchoPAC v113, 
GE Healthcare). Long-axis and mid-papillary level short-
axis B-mode images were used to measure left ventricu-
lar (LV) anterior (AW), posterior wall (PW) thicknesses 
and LV internal diameter (ID) in end-diastole (d) and in 
end-systole (s). End-systole was defined at minimal, while 
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end-diastole was defined at maximal LVID. Heart rate 
was determined from M-mode images taken at the mid-
papillary level in the short-axis view of the LV. Values of 
three consecutive cycles were averaged and used for sta-
tistical analysis. LV mass was calculated by the following 
equation: LVmass = 1.04 × [(LVAWd + LVIDd + LVPW
d)3 − LVIDd3]. LVmass was normalized to the tibia length 
and body weight [LVmass/tibia length (g/cm); LVmass/
body weight]. Fractional shortening (FS) was calculated 
as FS = (LVIDd − LVIDs)/LVIDd * 100.
Speckle‑tracking echocardiography
Loops of short-axis views of the mid-papillary level 
dedicated for speckle-tracking analysis were acquired at 
least three times using a constant frame rate (218  Hz). 
Analysis was performed in a blinded fashion by an expe-
rienced operator (EchoPAC v113). Segmental and global 
circumferential strain (GCS), circumferential systolic 
(SrS), isovolumic (SrIVR) and early diastolic (SrE) strain 
rate values were calculated (Fig. 1). Segmental and global 
radial strain (GRS) was also measured. Three differ-
ent short-axis loops from each animal and three cardiac 
cycles from each loop were analyzed. After manual delin-
eation of the endocardial border on end-diastolic frame, 
the software automatically divided the region of interest 
to six segments and tracked them throughout the cardiac 
cycles. In case of low tracking fidelity, manual correction 
was performed. Acceptance of a certain segment was 
guided by the recommendation of the software. Ideally, 
for each parameter (3 × 3 × 6) 54 segmental values are 
available. Based on our internal protocol [9], animals with 
< 36 segmental values available should not be included in 
statistical analysis. There was no such dropout in the cur-
rent experiment.
Hemodynamic measurements
Invasive hemodynamic investigation was performed 
as described previously [14]. A pressure-conductance 
microcatheter (SPR-838, Millar Instruments, Houston, 
TX, USA) was advanced into the LV. In case of T1DM, 
animals were anesthetized with pentobarbital sodium 
(60  mg/kg i.p.), while T2DM animals were anesthetized 
with isoflurane (1–2%). Systolic, diastolic and mean arte-
rial blood pressure (MAP), heart rate, LV end-systolic, 
end-diastolic pressures and volumes, stroke volume, 
ejection fraction (EF), cardiac output, stroke work, arte-
rial elastance (Ea), maximal slope of diastolic pressure 
increment (dP/dtmax), maximal slope of diastolic pres-
sure decrement (dP/dtmin), time constant of LV pressure 
decay  (TauG; Glantz-method), maximal power were cal-
culated. The slope of the LV end-systolic PV relationship 
(ESPVR; linear), preload recruitable stroke work (PRSW), 
maximal elastance  (Emax) and dP/dtmax—end-diastolic 
volume relationship were used as load- and heart rate-
independent indices of LV contractility. The slope of the 
LV end-diastolic PV relationship (EDPVR; linear) was 
determined as an index of LV diastolic stiffness. A special 
PV analysis software (PVAN, Millar Instruments) was 
used for data analysis. Heart weight (g) was measured 
after euthanization.
Histology
Five µm thin myocardial sections were stained with Mas-
son’s trichrome and hematoxylin–eosin staining. Inter-
stitial fibrosis (excluding vascular spaces) was evaluated 
on Masson’s trichrome stained sections. Briefly, fibrotic 
to total tissue area of the myocardium was determined 
by ImageJ software (NIH, Bethesda, MD, USA) using 
thresholding on red–green–blue stack images of Mas-
son’s trichrome sections by two independent observers. 
Cardiomyocyte hypertrophy was evaluated by the meas-
urement of cardiomyocyte diameter on hematoxylin–
eosin stained sections as described previously [14].
Statistics
Data are presented as mean ±  SEM. Shapiro–Wilk test 
was used to confirm normal distribution. Based on that, 
unpaired two-sided Student’s t test or Mann–Whitney 
U test was used to compare experimental groups to the 
corresponding control groups. Pearson or Spearman test 
was used for correlation analysis appropriately. Individual 
data of the diabetic animals were normalized to the mean 
of their corresponding control group. Diabetes associ-
ated percent changes were derived and compared with 
unpaired two-sided Student’s t test to compare changes 
between the two models. To test intra- and interobserver 
variability of STE measurements, 3 animals from each 
group were randomly selected and analyzed again using 
the aforementioned protocol by the first and also by a 
second operator blinded to previous results. Lin’s con-
cordance correlation coefficient values were calculated. A 
p < 0.05 was considered significant.
Results
Body weight and blood glucose
In T1DM diabetic animals showed significant 
decrease in body weight, while in T2DM it remained 
unchanged (Table  1). Blood glucose levels were 
increased in both DM (T1DM Co vs. T1DM: 7.6 ±  0.4 
vs. 33.1 ±  0.2  mmol/l, p  <  0.001; T2DM Co vs. T2DM: 
9.8 ± 0.6 vs. 27.0 ± 0.6 mmol/l, p < 0.001).
Echocardiography
T1DM was associated with significantly decreased wall 
thicknesses in diastole and in systole while LVIDd and 
LVIDs showed significant increase compared to controls 
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Fig. 1 Layout of speckle-tracking analysis. a Determination of circumferential strain on short-axis recordings. The negative peak of the curve 
represents the global circumferential strain (GCS). b Determination of circumferential strain rate on short-axis images. The peak negative value is 
the global circumferential strain rate in systole (SrS). The following peak represents the value of isovolumic relaxation (SrIVR) while the positive peak 
value is the early diastolic strain rate (SrE). Groups: animals with T1DM, their non-diabetic controls (T1DM Co); animals with T2DM and their non-
diabetic controls (T2DM Co). Arrows indicate the specific changes of strain and strain rate curves in DM
Table 1 Basic characteristics and conventional echocardiographic parameters of the study groups
The table shows the following parameters in the experimental groups: body weight, heart weight, heart weight/body weight, heart weight to tibia length, blood 
glucose, heart rate (during echocardiography), fractional shortening, left ventricular (LV) anterior (AW) and posterior wall (PW) thicknesses in systole (s) and in diastole 
(d), LV internal diameter (ID) in ‘s’ and ‘d’. Groups: animals with T1DM, their non-diabetic controls (T1DM Co); animals with T2DM and their non-diabetic controls (T2DM 
Co). * p < 0.05 vs. corresponding control group
Variable T1DM Co (n = 5) T1DM (n = 8) T2DM Co (n = 8) T2DM (n = 7)
Body weight (g) 529 ± 13 288 ± 23* 415 ± 9 394 ± 17
Heart weight (g) 1.50 ± 0.05 1.16 ± 0.09* 1.45 ± 0.02 1.48 ± 0.06
Heart weight/body weight (kg/g) 2.8 ± 0.1 4.0 ± 0.1* 3.5 ± 0.1 3.8 ± 0.2
Heart weight/tibia length (g/cm) 0.32 ± 0.01 0.28 ± 0.02 0.35 ± 0.01 0.37 ± 0.01*
Heart rate (beats/min) 364 ± 21 250 ± 10* 300 ± 6 292 ± 6
Fractional shortening (%) 51 ± 3 43 ± 2* 40 ± 2 42 ± 2
LVAWs (mm) 3.3 ± 0.9 2.5 ± 0.9* 2.5 ± 0.9 2.8 ± 0.9
LVAWd (mm) 2.2 ± 0.9 1.5 ± 0.9* 1.7 ± 0.9 1.9 ± 0.9*
LVIDs (mm) 3.0 ± 0.9 3.9 ± 1.0* 4.8 ± 1.0 4.7 ± 1.0
LVIDd (mm) 6.1 ± 1.0 6.9 ± 0.9* 8.1 ± 1.0 8.1 ± 1.0
LVPWs (mm) 3.5 ± 1.0 2.6 ± 0.9* 2.7 ± 0.9 3.2 ± 0.9*
LVPWd (mm) 2.4 ± 0.9 1.7 ± 0.9* 1.7 ± 0.9 2.2 ± 0.9*
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(Table  1). In spite of that, in LVAWd and LVPW values 
showed marked increase in T2DM animals in compari-
son to controls (Table  1) while LVID values remained 
unchanged. Additionally, FS decreased significantly in 
T1DM, while it was preserved in T2DM (Table 1).
Speckle‑tracking echocardiography
In T1DM animals, GCS and SrS values indicated 
clear systolic dysfunction compared to controls (Fig.  1 
and Fig. 2a). However, in the T2DM group only SrS was 
slightly, but significantly decreased versus control ani-
mals (Fig.  2a). SrIVR (suggested to be correlated with 
active relaxation) [15] was deteriorated in the T1DM 
model (Fig.  2b), while SrE was significantly reduced in 
T1DM and T2DM as well (Fig. 1 and Fig. 2b). GRS, along 
with segmental strain values, are reported in Additional 
file 1: Table S1.
Invasive hemodynamics
T1DM was associated with lower MAP and heart rate 
along with the significant worsening of contractile func-
tion as shown by decreased values of EF, cardiac output, 
ESPVR and PRSW versus control rats (Fig. 3 and Addi-
tional file  1: Table S2). On the other hand, MAP was 
similar, systolic function was preserved in the animal 
model of T2DM as represented by unchanged EF, cardiac 
output and ESPVR (Fig.  3 and Additional file  1: Table 
S2). PRSW showed a slight decrease in LV contractility 
in T2DM (Additional file  1: Table S2). On the contrary, 
we observed significant increase of EDPVR (a marker of 
cardiac stiffness) in the T2DM rats, while it increased 
slightly in T1DM (Fig. 3 and Additional file 1: Table S2). 
Additionally,  TauG was markedly increased in both DM 
models (Additional file  1: Table S2). However, dP/dtmin 
deteriorated only in T1DM and remained unchanged in 
T2DM (Additional file  1: Table S2). LVEDP increased 
only in T2DM (Additional file  1: Table S2). All relevant 
data generated and calculated by the PVAN software are 
reported in Additional file 1: Table S2.
Diabetes associated impairment of cardiac function
Regarding the cardiac function we observed different pat-
tern of hemodynamic alterations in T1DM and T2DM. 
Contractile function was more impaired in T1DM as 
shown by the values of ESPVR and PRSW and by STE 
parameters GCS and SrS (Fig.  4a). Regarding diastolic 
function, we observed more severe deterioration of active 
relaxation in T1DM (Fig.  4b), however, cardiac stiffness 
was more pronounced in T2DM (Fig.  4c). Accordingly, 
we observed significant correlations of the parameters of 
Fig. 2 Results of speckle-tracking echocardiography. a Graphs show systolic parameters: global circumferential strain (GCS) and peak strain rate 
values in systole (SrS). b Graphs show diastolic parameters: peak strain rate at isovolumic relaxation (SrIVR) and in early diastole (SrE) in the groups. 
Groups: animals with T1DM, their non-diabetic controls (T1DM Co); animals with T2DM and their non-diabetic controls (T2DM Co). *p < 0.05 vs. 
corresponding controls
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GCS and SrS with the contractile parameters of the PV 
analysis in T1DM (Fig. 4d; GCS and PRSW r = − 0.672, 
p < 0.05; SrS and PRSW r = − 0.786, p < 0.01). In addition 
to that, markers of active relaxation  TauG and dP/dtmin 
correlated with SrIVR in T1DM (Fig. 4e), while the myo-
cardial stiffness parameter EDPVR correlated with SrE in 
T2DM (Fig. 4f; EDPVR and SrE r = 0.800, p < 0.001).
EDPVR and SrE correlate with myocardial hypertrophy 
in T2DM
Although heart weight was significantly lower in T1DM, 
the heart weight/body weight ratio was increased in 
T1DM animals (Table  1). Additionally, these parameters 
did not change significantly in T2DM (Table 1). However, 
heart weight/tibia length ratio was increased in T1DM 
animals when compared to the controls (Table 1). Inter-
estingly, echocardiographic analysis revealed increased 
LVmass/body weight values in both models (Fig.  5a) 
while LVmass/tibia length showed significant decrease in 
T1DM (Fig. 5a) and marked increase in T2DM (Fig. 5a). 
The sensitive parameter of cardiac stiffness, EDPVR, 
along with SrE correlated significantly with the extent 
of myocardial hypertrophy in T2DM. Of note, EDPVR 
and SrE correlated with the echocardiography-derived 
LVmass/tibia length ratio (Fig.  5b; EDPVR r  =  0.641, 
p < 0.05; SrE r = − 0.562, p < 0.05). Moreover, histological 
analysis (Fig. 5c) revealed the significant elevation of car-
diomyocyte diameter in both models (Fig. 6a) and EDPVR 
and SrE showed closer correlations with the hypertrophy 
of individual cardiomyocytes (represented by cardiomyo-
cyte diameter) on a histological level (Fig.  6b; EDPVR 
r = 0.779, p < 0.01; SrE r = − 0.698, p < 0.01). 
EDPVR and SrE correlate with myocardial fibrosis in T2DM
As a sign of myocardial remodeling, fibrosis of the LV 
was evident in both models (Fig. 7a, b). It is worth not-
ing that not only cardiac hypertrophy but also myocardial 
fibrosis is a determinant of cardiac stiffness since the val-
ues of EDPVR and also STE-derived SrE correlated with 
the fibrotic area of the LV (Fig. 7c).
Intra‑ and interobserver variability of STE parameters
Intraclass correlation coefficient values were the highest 
in terms of SrS (intra-reader and inter-reader: 0.982 and 
0.969, respectively). GCS showed almost no difference 
between intra- and interobserver variability (0.950 and 
0.947). SrE (0.971 and 0.929) and SrIVR (0.969 and 0.922) 
had similar intra-, while lower interobserver reproduc-
ibility. Intraclass correlation coefficient values of GRS 
were lower (0.876 and 0.811).
Fig. 3 Representative pressure–volume loops. The figure shows representative left ventricular pressure–volume (PV) loops of the animals. Red line: 
end-systolic PV relationship; green line: end-diastolic PV relationship. Arrows indicate the change of PV relationships (red arrow: decrease in end-
systolic PV relationship, green arrow: increase in end-diastolic PV relationship). Groups: animals with T1DM, their non-diabetic controls (T1DM Co); 
animals with T2DM and their non-diabetic controls (T2DM Co)
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Discussion
In the present study we showed that: (a) STE-derived 
measurements are sensitive in the detection of diabetes 
associated impairment of cardiac contractility as well as 
diastolic function, (b) STE-derived parameters correlate 
with cardiac contractility, active relaxation and stiffness 
measured by PV analysis and (c) indices of STE correlate 
with the markers of histological remodeling (hypertrophy 
and fibrosis) in T2DM related diabetic cardiomyopathy.
The rat model of streptozotocin-induced T1DM and 
the ZDF rat as a model of T2DM are widely used in stud-
ies focusing on the characterization of diabetic cardio-
myopathy. Depending on the type of DM it is associated 
with characteristic changes in body weight and blood 
glucose levels. T1DM is associated with insulinopenia 
and weight loss, while T2DM is often associated with 
obesity and hyperinsulinemia [1, 16]. In line with these 
observations, we found increased blood glucose levels in 
both models, however, body weight was lower in T1DM 
while it did not change in T2DM.
Characterization of cardiac performance is challenging 
in DM due to the changes in MAP and heart rate [10]. 
These phenomena might contribute to the difficulties 
of the comparison of cardiac function in these models 
with conventional techniques. Transthoracic echocardi-
ography is the most commonly used imaging modality 
as it allows detailed morphological and functional char-
acterization of the heart, while still remaining radiation 
free and cost-effective. However, conventional param-
eters suffer from several shortcomings including modest 
Fig. 4 Diabetes associated impairment of systolic and diastolic function in diabetes. a Diabetes associated impairment of the following con-
tractile parameters in type-1 and type-2 diabetes mellitus (T1DM, T2DM): end-systolic pressure–volume relationship (ESPVR), preload recruitable 
stroke work (PRSW), global circumferential strain (GCS) and the peak strain rate values in systole (SrS). b Diabetes associated alteration of diastolic 
parameters  TauG, maximal slope of diastolic decrement (dP/dtmin) and strain rate at isovolumic relaxation (SrIVR) are shown. c Diabetes associated 
alteration of the slope of end-diastolic pressure–volume relationship (EDPVR), left ventricular end-diastolic pressure (LVEDP) and strain rate in early 
diastole (SrE) are shown. d Correlation analyses of GCS and SrS to ESPVR and PRSW are shown. e Correlation analyses of active relaxation parameter 
SrIVR to  TauG and dP/dtmin are shown. f Correlation analyses of SrE to EDPVR and LVEDP are shown. Groups: animals with T1DM, their non-diabetic 
controls (T1DM Co); animals with T2DM and their non-diabetic controls (T2DM Co). *p < 0.05 T1DM vs. T2DM
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Fig. 5 Cardiac stiffness correlates with the extent of myocardial hypertrophy. a Graphs of left ventricular (LV) mass to body weight (LVmass/body 
weight) and to tibia length (LVmass/tibia length) are shown. b Results of correlation analysis of LVmass/tibia length to the slope of end-diastolic 
pressure–volume relationship (EDPVR) and to early diastolic strain rate (SrE). c Representative hematoxylin–eosin stained sections. Magnification: 
×400. Marker: 100 µm. *p < 0.05 vs. corresponding controls
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sensitivity and reproducibility, resulting in moderate 
correlations with invasive measurements [11]. Develop-
ment of software technology permitted frame-by-frame 
tracking of the myocardial echogenic pattern and this 
non-Doppler approach defines several advanced param-
eters referring to systolic and diastolic function [17]. 
Strain measurements may notably overcome the afore-
mentioned limitations by reflecting intrinsic myocardial 
function and also by being a semi-automated method. 
Sensitivity of strain measures were proved in numer-
ous pathological conditions in human and also in animal 
experiments [18, 19] including diabetic cardiomyopathy 
[4, 20–23]. Furthermore, in our recent work, we were 
able to show correlations between STE and PV analy-
sis derived measures in a rat model of increased cardiac 
contractility [9]. Here, we found that GCS and SrS can 
demonstrate the overt systolic dysfunction in T1DM 
and correlate well with invasively measured contractil-
ity. However, technical setup of our experiment allows 
detailed characterization of diastole as well. In our cur-
rent work, SrIVR was reduced significantly in T1DM, 
while the deterioration of SrE was more pronounced in 
T2DM. This parallels with the invasive PV analysis show-
ing more evident deterioration of active relaxation in 
T1DM along with pronounced increase in LV stiffness 
in T2DM. Previously, SrIVR has been shown to be asso-
ciated with  TauG [24]. In our study, this association was 
also present in T1DM animals. Additionally, a correla-
tion between SrE and the stiffness parameters EDPVR 
and LVEDP was shown in T2DM. Formerly, decrease 
of circumferential strain was demonstrated in a mouse 
model of T2DM [25], while most recently Shepherd et al. 
published their data on T1DM highlighting the early sen-
sitive nature of STE during consecutive evaluation com-
pared to conventional echocardiographic parameters 
[26]. Based on these previous results, STE is now increas-
ingly used in human clinical trials to unmask and follow-
up subtle alterations in LV function [27]. Moreover, STE 
is also capable to assess right ventricular and also atrial 
deformation, which measurements will contribute to a 
more complex understanding of diabetic cardiomyopathy 
[28, 29].
Depending on its type, DM is associated with charac-
teristic changes of cardiac function. Diastolic dysfunc-
tion is an early sign in DM associated cardiomyopathy 
before the onset of detectable systolic dysfunction [3]. 
However, T1DM animals have been shown to exert not 
only diastolic but systolic cardiac dysfunction already 
Fig. 6 Cardiac stiffness correlates with the extent of myocardial hypertrophy. a Analysis of cardiomyocyte diameter in the study groups. b Correla-
tion analyses of cardiomyocyte diameter to EDPVR and SrE. Groups: animals with T1DM, their non-diabetic controls (T1DM Co); animals with T2DM 
and their non-diabetic controls (T2DM Co). *p < 0.05 vs. corresponding controls
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Fig. 7 Cardiac stiffness correlates with myocardial fibrosis. a Masson’s trichrome stained images. Magnification: ×100. Marker: 100 µm. b Quantifi-
cation of fibrotic area in the study groups. c Result of correlation analysis of EDPVR and SrE to fibrotic area. Groups: animals with T1DM, their non-
diabetic controls (T1DM Co); animals with T2DM and their non-diabetic controls (T2DM Co). *p < 0.05 vs. corresponding controls
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at early time-points during the progression of the dis-
ease [3, 16, 26, 30, 31]. According to our previous work, 
streptozotocin-induced (insulin-dependent) T1DM asso-
ciated diabetic cardiomyopathy is characterized by the 
impairment of systolic function and by the prolongation 
of active relaxation [6]. Contractility and active relaxa-
tion are highly energy-dependent processes that are 
greatly affected by the disturbances of insulin signaling 
[3]. Accordingly, we observed more pronounced impair-
ment of the energy-dependent measures of systolic func-
tion (EF, cardiac output, ESPVR, PRSW; GCS, SrS) and 
active relaxation  (TauG, dP/dtmin; SrIVR) in our T1DM 
model by PV analysis and by STE. On the contrary, our 
T2DM animal model has been shown to develop insulin 
resistance together with hyperinsulinemia and insulin-
openia at a later stage of the disease [32]. Accordingly, 
systolic function is preserved along with the impairment 
of diastolic function in the T2DM rat model [6]. Our 
present results are in line with the above findings as sys-
tolic parameters (EF, cardiac output, ESPVR; GCS) did 
not change significantly in T2DM. However, LV com-
pliance indices were markedly altered (LVEDP, EDPVR) 
in T2DM, which is in line with our previous results [6, 
16]. Additionally, we observed a significant drop in MAP 
and heart rate in T1DM while they did not change in 
T2DM. End-diastolic stiffness is predominantly affected 
by the changes of myocardial structure [33] including 
cardiomyocyte hypertrophy and fibrotic remodeling [34]. 
Consistently, we found increased LVEDP and EDPVR in 
T2DM while SrE was also markedly reduced. In the back-
ground of the increased diastolic stiffness we observed 
hypertrophic and fibrotic remodeling of the myocardium 
in T2DM. Of note, our sensitive hemodynamic param-
eter EDPVR along with STE-derived SrE correlated 
with the extent of cardiomyocyte hypertrophy and with 
the amount of interstitial fibrosis. Previous studies have 
also reported that STE is a useful tool in the assessment 
of myocardial fibrosis as global and segmental strain 
parameters correlated with interstitial fibrosis and car-
diomyocyte area in animal models of uremic [35] and 
hypertrophic cardiomyopathy [36] as well as in humans 
with Fabry-disease [37] and hypertrophic cardiomyopa-
thy [38]. However, to our knowledge this is the first study 
that shows that the impairment of SrE could refer to the 
extent of cardiac hypertrophy and fibrosis. Additionally, 
to our knowledge our study firstly reports about the cor-
relation between EDPVR, SrE and histological markers of 
hypertrophy and interstitial fibrosis.
Limitations
Our study has some assumptions and limitations. Firstly, 
the number of investigated animals may serve as a limita-
tion, however, the current case numbers are reasonable 
in experimental studies and are based on previous statis-
tical calculations (power analysis). This should also affect 
some of the calculated correlation coefficients, where 
beyond the peak values, the dispersion of data is higher 
in the mid-range. While we should be cautious with the 
interpretation of the exact r values, the presence of a cor-
relation is assured. Second, the echocardiographic hard-
ware and software environment is not dedicated to small 
animal models. Nevertheless, the correlations with PV 
analysis, and also the reported intra- and interobserver 
values suggest that both the sensitivity and the reproduc-
ibility of our setup is comparable to dedicated, higher 
frequency systems [12, 39]. Longitudinal strain, which is 
the most robust parameter in human settings, is absent 
in this work due to the lack of sufficient apical window 
in rats and due to its less reliable measurement from 
available long-axis images. However, it has been exten-
sively shown that both regional and global STE param-
eters derived from short-axis recordings could be feasible 
and meaningful measurements in various pathological 
conditions and experimental settings [40–42]. Beyond 
cardiomyocyte diameter, myocardial hypertrophy is also 
described by the calculation of LV mass, an M-mode 
measurement relying on geometrical assumptions. The 
inherent error in the calculation may have caused the 
modest correlation with stiffness parameters.
Conclusions
According to our knowledge, this is the first study to 
compare STE-derived systolic and also diastolic func-
tional measurements with PV analysis in detecting the 
characteristic differences between T1DM- and T2DM-
associated cardiac dysfunction in experimental ani-
mal models. Based on our results, strain and strain rate 
parameters might be valuable and feasible measures to 
describe the dynamic changes in contractility, active 
relaxation and LV stiffness in animal models of T1DM 
and T2DM by serial assessment. Moreover, these param-
eters may be reliable tools for experimental studies focus-
ing on the pathophysiology and on the monitoring of 
therapeutic interventions in both type-1 and type-2 DM.
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